tradingkey.logo
搜尋

Metagenomi Inc

MGX
添加自選
1.260USD
+0.050+4.13%
收盤 07/02, 13:00美東報價延遲15分鐘
47.44M總市值
虧損本益比TTM

關於 Metagenomi Inc 公司

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Metagenomi Inc簡介

公司代碼MGX
公司名稱Metagenomi Inc
上市日期Feb 09, 2024
CEOIrish (Jian)
員工數量202
證券類型Ordinary Share
年結日Feb 09
公司地址5959 Horton St
城市EMERYVILLE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94608
電話15108714880
網址https://metagenomi.co/
公司代碼MGX
上市日期Feb 09, 2024
CEOIrish (Jian)

Metagenomi Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--

常見問題

Metagenomi Inc的前五大股東是誰?

Metagenomi Inc的前五大股東如下:Dr. Brian C. Thomas, Ph.D.

有多少機構持有Metagenomi Inc(MGX)的股份?

截至2026Q1,共有172家機構持有Metagenomi Inc的股份,合計持有的股份價值約為8.82M,占公司總股份的23.43% 。與2025Q4相比,機構持股有所增加,增幅為-6411264.00。